Case Study

FIVE REASONS THE MAJORITY OF EXTERNAL COLLABORATIONS FAIL

FIVE REASONS THE MAJORITY OF EXTERNAL COLLABORATIONS FAIL

Pages 6 Pages

FIVE REASONS THE MAJORITY OF EXTERNAL COLLABORATIONS FAIL (AND HOW TO OVERCOME THEM) White PaperThis white paper, brought to you by Dassault Systèmes BIOVIA, discusses the different types of external collaborations research organizations engage in, the reasons that many of these partnerships fail to meet expectations, and an informatics solutions to overcome these issues. Drug discovery is an arduous and costly endeavor that offers no guarantee of success. In an effort to accelerate innovation, streamline the R&D process, satisfy healthcare expectations and improve the rate of return, pharmaceutical companies have come to embrace external collaborations and their outsourcing partners as an essential part of their discovery programs. This trend towards externalization is signific

Join for free to read